Jeffrey W. Mittleman is a partner in the Business Section of Holland & Knight. He is also co-leader of the firm’s Healthcare & Life Sciences Industry Group and a member of the Compliance Services Team. He practices in the areas of health, regulatory and corporate law. With more than 20 years of experience, he represents clients in a variety of sectors within the healthcare industry, including health plans (both fully and self-insured), PPOs, HMOs, insurers, pharmacy benefit managers, pharmaceutical manufacturers (including a number of companies specializing in oncology medicine), medical device companies, retail pharmacies, long-term care pharmacies, specialty pharmacies, compounding pharmacies, mail order pharmacies, wholesale drug distributors, dialysis companies, e-health, disease management and healthcare technology companies. Mr. Mittleman counsels clients in a variety of corporate and contractual transactions, including mergers and acquisitions, joint ventures, licensing, financing and services-related transactions. He also advises clients in fraud and abuse defense, the structuring of compliance and ethics programs, Medicare, Medicaid, ERISA, HIPAA, licensing, state insurance and managed care law. In addition, Mr. Mittleman has significant experience advising health plans in connection with the drafting of plan documents, ASO contracting and other regulatory issues.
Mr. Mittleman represents private equity firms in connection with investments in portfolio companies that are engaged in the healthcare and life sciences industries. He guides private equity clients through every stage of an acquisition, from evaluation of the opportunity and due diligence to deal structuring and negotiation to closing.